Key result
Bedside modalities revealed a high prevalence of neuropathy in children and adolescents with type 1 diabetes, including DPN in 40% and early CAN in 17%.
Why the study?
The prevalence and co-existence of diabetic polyneuropathy, cardiac autonomic neuropathy, and sudomotor dysfunction in children and adolescents with type 1 diabetes evaluated with bedside modalities remained to be investigated.
What is the prevalence of diabetic polyneuropathy, cardiac autonomic neuropathy, and sudomotor dysfunction in children and adolescents with type 1 diabetes evaluated with bedside modalities?
Cross-Sectional (n=221)
What is the prevalence of diabetic polyneuropathy, cardiac autonomic neuropathy, and sudomotor dysfunction in children and adolescents with type 1 diabetes evaluated with bedside modalities?
Bedside modalities reveal a high prevalence of neuropathy, including cardiac autonomic neuropathy, in children and adolescents with type 1 diabetes despite good glycemic control and short disease duration.
May support multi-neuropathy screening in pediatric T1D; leaves open progression risk and screening impact.
AIMS: To investigate the prevalence of diabetic polyneuropathy (DPN), cardiac autonomic neuropathy (CAN) and sudomotor dysfunction in children and adolescents with type 1 diabetes using bedside modalities. Secondly, to evaluate the co-existence of these types of diabetes neuropathies. METHODS: Cross-sectional study including 221 children and adolescents with type 1 diabetes. DPN was assessed by vibration sensation threshold and sural nerve conductance, CAN by cardiac reflex tests and sudomotor function by electrochemical skin conductance. RESULTS: Median (interquartile range) age was 14.2 (11.9, 16.5) years, diabetes duration 4.8 (2.7, 7.7) years and Hba1c 7.1 (6.6, 7.9) %, (54: 49, 63 mmol/mol). Three had retinopathy; all had normal albuminuria. DPN was present in 40 %, early CAN in 17 %, established CAN in 3 % and sudomotor dysfunction in the feet in 5 %. Of these, 60 % had one type of neuropathy, while 35 % had two types. Only 1 participant manifested all three types of neuropathies. CONCLUSIONS: Bedside modalities demonstrated a high prevalence of neuropathy in children and adolescents with type 1 diabetes, despite good glycemic outcome, short diabetes duration and absence of complications. A lack of co-existing neuropathies was shown, underscoring the need for multiple screening modalities.
No takes yet. Share an insight, caveat, or question.
Damm et al. (2024) conducted a cross-sectional in type 1 diabetes (n=221). Bedside modalities for neuropathy screening was evaluated on Prevalence of diabetic polyneuropathy (DPN). Bedside modalities revealed a high prevalence of neuropathy in children and adolescents with type 1 diabetes, including DPN in 40% and early CAN in 17%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: